Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single- and Multiple-Dose Safety and PK Study of Lu AG06466 in Healthy Japanese and Caucasian Adults
jRCT2031210465Phase 1Suspended
- Sponsor
- Lundbeck
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ABX-1431 in neurobehavioral conditions (4 arms), sponsored by Lundbeck. Started Nov 2021; status: suspended.
02
Drugs
ABX-1431
03
Conditions
neurobehavioral conditions
Beyond the preview
Go deeper on jRCT2031210465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210465.